Generic Animal Drug Advancement Act
United States117th CongressHR-8857House of Representatives
Updated: Sep 16, 2022
Summary
Generic Animal Drug Advancement Act This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)
Bill texts
All available records shown.
Timeline
Introduced in House
Referred to the House Committee on Energy and Commerce.
House of Representatives
Referred to the Subcommittee on Health.
House of Representatives
All available records shown.